Novel Compositions and Adjuvants

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110171259A1
SERIAL NO

13061841

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed toward adjuvants that effect an innate and/or a specific immune response. The adjuvants contain at least one lipoprotein, such as Lip, Lip fragments or Lip variants, where the lipoprotein comprises at least one pentameric unit and at least one lipid moiety. Adjuvants wherein the lipoprotein make up at least 10% of the adjuvant by weight/volume are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ID BIOMEDICAL CORPORATION OF QUEBECLAVAL QC H7V 3S8

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gagne, Martin Laval, CA 25 526
Larocque, Daniel Laval, CA 15 158
Plante, Martin Laval, CA 18 938

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation